Antonia Feola

Dr. Antonia Feola

Department of Biology, University of Naples "Federico II", Italy
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2012 in Journal of Biomedicine and Biotechnology
Verified
Journal Article
Open access
PDF file
MDMarina Di Domenico
Marina Di Domenico
Fabrizia d'ApuzzoFabrizia d'Apuzzo
Fabrizia d'Apuzzo
Antonia FeolaAntonia Feola
Antonia Feola
LCL. Cito
L. Cito
AMA. Monsurrò
A. Monsurrò
LPLetizia Perillo
Letizia Perillo
Orthodontics is a branch of dentistry that aims at the resolution of dental malocclusions. The specialist carries out the treatment using intraoral or extraoral orthodontic appliances that require forces of a given load level to obtain a tooth movement in a certain direction in dental arches. Orthodontic tooth movement is dependent on efficient remodeling of periodontal ligament and alveolar bone, correlated with several biological and mechanical responses of the tissues surrounding the teeth. A periodontal ligament placed under pressure will result in bone resorption whereas a periodontal ligament under tension results in bone formation. In the primary stage of the application of orthodontic forces, an acute inflammation occurs in periodontium. Several proinflammatory cytokines are produced by immune-competent cells migrating by means of dilated capillaries. In this paper we summarize, also through the utilization of animal models, the role of some of these molecules, namely, interleukin-1βand vascular endothelial growth factor, that are some proliferation markers of osteoclasts and osteoblasts, and the macrophage colony stimulating factor.

31 March 2014 in Current Cancer Drug Targets
Verified
Journal Article
Closed access
PDF file
GPG. Pannone
G. Pannone
Angela santoroAngela santoro
Angela santoro
Antonia FeolaAntonia Feola
Antonia Feola
PBP. Bufo
P. Bufo
PPP. Papagerakis
P. Papagerakis
MDMarina Di Domenico
Marina Di Domenico
Background: The prognosis of the oral squamous cell carcinoma (OSCC) patients remains very poor, mainly due to their high propensity to invade and metastasize. E-cadherin reduced expression occurs in the primary step of oral tumour progression and gene methylation is a mode by which the expression of this protein is regulated in cancers. In this perspective, we investigated E-cadherin gene (CDH1) promoter methylation status in OSCC and its correlation with Ecadherin protein expression, clinicopathological characteristics and patient outcome. Methods: Histologically proven OSCC and paired normal mucosa were analyzed for CDH1 promoter methylation status and E-cadherin protein expression by methylation-specific polymerase chain reaction and immunohistochemistry. Colocalization of E-cadherin with epidermal growth factor (EGF) receptor (EGFR) was evidenced by confocal microscopy and by immunoprecipitation analyses. Results: This study indicated E-cadherin protein down-regulation in OSCC associated with protein delocalization from membrane to cytoplasm. Low E-cadherin expression correlated to aggressive, poorly differentiated, high grade carcinomas and low patient survival. Moreover, protein down-regulation appeared to be due to E-cadherin mRNA downregulation and CDH1 promoter hypermethylation. In an in vitro model of OSCC the treatment with EGF caused internalization and co-localization of E-cadherin with EGFR and the addition of demethylating agents increased E-cadherin expression. Conclusion: Low E–Cadherin expression is a negative prognostic factor of OSCC and is likely due to the hypermethylation of CDH1 promoter. The delocalization of E-cadherin from membrane to cytoplasm could be also due to the increased expression of EGFR in OSCC and the consequent increase of E-cadherin co-internalization with EGFR.

27 June 2020 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
Maria ContaldoMaria Contaldo
Maria Contaldo
Mariarosaria BoccellinoMariarosaria Boccellino
Mariarosaria Boccellino
GZGiuseppa Zannini
Giuseppa Zannini
ARAntonio Romano
Antonio Romano
ASAntonella Sciarra
Antonella Sciarra
MDMarina Di Domenico
Marina Di Domenico
Oral cancers have been proven to arise from precursors lesions and to be related to risk behaviour such as alcohol consumption and smoke. However, the present paper focuses on the role of chronic inflammation, related to chronical oral infections and/or altered immune responses occurring during dysimmune and autoimmune diseases, in the oral cancerogenesis. Particularly, oral candidiasis and periodontal diseases introduce a vicious circle of nonhealing and perpetuation of the inflammatory processes, thus leading toward cancer occurrence via local and systemic inflammatory modulators and via genetic and epigenetic factors.

1 January 2014 in The Scientific World Journal
Verified
Journal Article
Open access
PDF file
Erika Di ZazzoErika Di Zazzo
Erika Di Zazzo
Antonia FeolaAntonia Feola
Antonia Feola
CZCandida Zuchegna
Candida Zuchegna
ARA. Romano
A. Romano
CDC. F. Donini
C. F. Donini
APAntonio Porcellini
Antonio Porcellini
Recent studies have shown that hyperinsulinemia may increase the cancer risk. Moreover, many tumors demonstrate an increased activation of IR signaling pathways. Phosphatidylinositol 3-kinase (PI3K) is necessary for insulin action. In epithelial cells, which do not express GLUT4 and gluconeogenic enzymes, insulin-mediated PI3K activation regulates cell survival, growth, and motility. Although the involvement of the regulatory subunit of PI3K (p85αPI3K) in insulin signal transduction has been extensively studied, the function of its N-terminus remains elusive. It has been identified as a serine (S83) in thep85αPI3Kthat is phosphorylated by protein kinase A (PKA). To determine the molecular mechanism linking PKA to insulin-mediated PI3K activation, we usedp85αPI3Kmutated forms to prevent phosphorylation (p85A) or to mimic the phosphorylated residue (p85D). We demonstrated that phosphorylation ofp85αPI3KS83 modulates the formation of thep85αPI3K/IRS-1complex and its subcellular localization influencing the kinetics of the insulin signaling both on MAPK-ERK and AKT pathways. Furthermore, thep85αPI3KS83 phosphorylation plays a central role in the control of insulin-mediated cell proliferation, cell migration, and adhesion. This study highlights thep85αPI3KS83 role as a key regulator of cell proliferation and motility induced by insulin in MCF-7 cells breast cancer model.

11 August 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MLMonica Lamberti
Monica Lamberti
RCRosanna Capasso
Rosanna Capasso
AAngela Lombardi
Angela Lombardi
MDMarina Di Domenico
Marina Di Domenico
Alfonso FiorelliAlfonso Fiorelli
Alfonso Fiorelli
DIDiego Ingrosso
Diego Ingrosso
Pleural malignant mesothelioma (MPM) is a detrimental neoplasm affecting pleural sheets and determining a high rate of mortality. In this study, we have enrolled 14 consecutive patients (13 males and 1 female) with MPM (mean age: 70.3 ± 4.6 years). We have collected serum for the determination of a miRNA profiling using a low-density microarray real time PCR system in the serum of patients and comparing it with that one of 10 control counterparts affected by not-cancer-related pleural effusions. In the patients 5 miRNAs were up-regulated (miR101, miR25, miR26b, miR335 and miR433), 2 miRNA were downregulated (miR191, miR223) and two miRNAs were expressed exclusively in patients (miR29a and miR516). Based upon the changes in the expression of the above mentioned miRNAs we detected two distinctive miRNA signatures predicting histotype and survival in these patients: I) patients with more than 3/9 upregulated miRNAs or 3/9 upregulated miRNAs and miR516 not recordable or unchanged (signature A); II) patients with at least 3/9 downregulated or unchanged miRNAs and/or miR29a downregulated (signature B). Based upon these criteria, 5 patients were stratified in signature A and the remaining 9 in signature B. Patients with signature A had a significant shorter median survival than those with signature B (7 months vs. 17 months, 95% CI: 0.098–1.72, p = 0.0021), had a sarcomatoid or mixed histological MPM subtype and were diagnosed in stage II (3/5) and stage III (2/5). In conclusion, we suggest that miRNA signature A is predictive of sarcomatoid histotype and of worse prognosis in MPM.

21 July 2016 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
Antonia FeolaAntonia Feola
Antonia Feola
SRSerena Ricci
Serena Ricci
SKSoumaya Kouidhi
Soumaya Kouidhi
ARAntonietta Rizzo
Antonietta Rizzo
APAntonella Penon
Antonella Penon
MDMarina Di Domenico
Marina Di Domenico